MUC1 and pachyonychia congenita: In addition, we first induced an initial T-cell response with a novel vaccinia virus vector expressing the tumor antigens CEA and MUC-1, as well as three co-stimulatory molecules, followed by an enhanced immune response with the same expression of a non-replicating fowlpox virus in PC patients.